Apellis Pharmaceuticals
Latest round
- Series E
Last raised
- Aug 2017
Total raised
- $147M
Investors
- 16
About Apellis Pharmaceuticals
Founded in 2009, Apellis Pharmaceuticals, Inc. is based in Waltham, US. The company specializes in creating therapies for complement-mediated diseases. Cedric Francois, one of the co-founders, leads as CEO.Apellis Pharmaceuticals specializes in innovative therapies for complement-mediated diseases, with APL-2 being its flagship complement inhibitor. This product is designed to treat geographic atrophy, a progressive retinal disease.12 mn. The company's strategy also includes expanding into new international markets to enhance patient access to its innovative therapies.
Who invested in Apellis Pharmaceuticals
16 investors across 5 rounds
See all investors in Apellis Pharmaceuticals
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Apellis Pharmaceuticals
Who invested in Apellis Pharmaceuticals?
Apellis Pharmaceuticals has 16 investors on record across 5 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Apellis Pharmaceuticals raised?
Apellis Pharmaceuticals has raised 5 venture rounds. Sign up free to see how much each round raised and the total.
When did Apellis Pharmaceuticals last raise money?
Apellis Pharmaceuticals's most recent round on record is a Series E, in Aug 2017.
What does Apellis Pharmaceuticals do?
Founded in 2009, Apellis Pharmaceuticals, Inc.
Where is Apellis Pharmaceuticals headquartered?
Apellis Pharmaceuticals is headquartered in Waltham, US.
Which VCs invest in companies like Apellis Pharmaceuticals?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Apellis Pharmaceuticals's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series E
Raising like Apellis Pharmaceuticals? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.